Advertisement
Screener

MARRONE BIO INNOVATIONS INC. Proceeds from Common Stock Issued

MARRONE BIO INNOVATIONS INC. Proceeds from Common Stock Issued

MARRONE BIO INNOVATIONS INC. reported Proceeds from Common Stock Issued of $34.49 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-16.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2020-03-16

  • MARRONE BIO INNOVATIONS INC. proceeds from issuance of common stock for the quarter ending 2018-12-31 was $1.00K.
  • MARRONE BIO INNOVATIONS INC. proceeds from issuance of common stock for the quarter ending 2018-09-30 was -$11.00K.
  • MARRONE BIO INNOVATIONS INC. proceeds from issuance of common stock for the quarter ending 2018-06-30 was $12.68M.
  • MARRONE BIO INNOVATIONS INC. proceeds from issuance of common stock for the quarter ending 2018-03-31 was $21.82M.
  • MARRONE BIO INNOVATIONS INC. proceeds from issuance of common stock for fiscal 2018 was $34.49M, a 321.18% increase from fiscal 2017.
  • MARRONE BIO INNOVATIONS INC. proceeds from issuance of common stock for fiscal 2017 was $8.19M, a 45.41% decline from fiscal 2016.
  • MARRONE BIO INNOVATIONS INC. proceeds from issuance of common stock for fiscal 2016 was $15.00M.
  • MARRONE BIO INNOVATIONS INC. proceeds from issuance of common stock for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
Period endProceeds from Issuance of Common Stock 1 monthProceeds from Issuance of Common Stock 1 month as first filedProceeds from Issuance of Common Stock 3 monthProceeds from Issuance of Common Stock 6 monthProceeds from Issuance of Common Stock 9 monthProceeds from Issuance of Common Stock 12 month
2018-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
-$10.00K
derived: sum of 2 quarters · filed 2020-03-16
$12.67M
derived: sum of 3 quarters · filed 2020-03-16
$34.49M
10-K · filed 2020-03-16
2018-09-30-$11.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-19
$12.66M
derived: sum of 2 quarters · filed 2019-11-19
$34.48M
10-Q · filed 2019-11-19
$34.48M
derived: sum of 4 quarters · filed 2019-11-19
2018-06-30$12.68M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$34.50M
10-Q · filed 2019-08-09
$34.50M
derived: sum of 3 quarters · filed 2019-08-09
$34.46M
derived: sum of 4 quarters · filed 2019-08-09
2018-04-30$12.66M
10-K · filed 2020-03-16
$12.68M
10-Q · filed 2018-08-14
2018-03-31$21.82M
10-Q · filed 2019-05-10
$21.82M
derived: sum of 2 quarters · filed 2019-05-10
$21.79M
derived: sum of 3 quarters · filed 2019-05-10
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
-$35.00K
derived: sum of 2 quarters · filed 2019-03-29
$8.19M
10-K · filed 2019-03-29
2017-09-30-$35.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
$8.19M
10-Q · filed 2018-11-14
2017-06-30$8.22M
10-Q · filed 2018-08-14
2017-04-30$8.19M
10-K · filed 2019-03-29
2016-12-31$50.00M
10-K · filed 2018-04-05
$15.00M
10-K · filed 2019-03-29
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$0.00
derived: sum of 2 quarters · filed 2016-03-30
$0.00
10-K · filed 2016-03-30
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16
$0.00
10-Q · filed 2015-11-16
2015-06-30$0.00
10-Q · filed 2015-11-10
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-03
-$10.00K
derived: sum of 2 quarters · filed 2017-04-03
$39.95M
10-K · filed 2017-04-03
2014-09-30-$10.00K
derived: 10-Q 9 month − 10-K 6 month · filed 2015-11-16
$39.95M
10-Q · filed 2015-11-16
2014-06-30$39.95M
10-K · filed 2017-04-03
$39.96M
10-K · filed 2015-11-10
2013-12-31$0.00
derived: 10-K 12 month − 10-K 9 month · filed 2016-03-30
$56.10M
derived: sum of 2 quarters · filed 2016-03-30
$56.10M
10-K · filed 2016-03-30
2013-09-30$56.10M
derived: 10-K 9 month − 10-Q 6 month · filed 2015-11-10
$56.10M
10-K · filed 2015-11-10
2013-06-30$0.00
10-Q · filed 2014-08-13
2012-12-31$0.00
10-K · filed 2015-11-10